JRS Pharma Adds Povidone Product Line
PTSM: Pharmaceutical Technology Sourcing and Management
Excipient manufacturer adds three tablet binding and disintegration products.
JRS Pharma announced the expansion its line of excipients for tablet binding and disintegration with a Feb. 28, 2017 press statement about a povidone product line that features Vivapharm PVP (povidone) wet binder, Vivapharm PVP/VA 64 (copovidone) tablet binder, and Vivapharm PVPP (crospovidone) to facilitate disintegration performance.
The company reports that the excipients are manufactured in a GMP and ISO 9001 compliant/certified production facility and comply with current compendial requirements in the European, US, and Japanese.
The company reports that it conducts on-site quality checks and final quality control and release in the Analytical Competence Center at the JRS Pharma facilities in Germany.
The company reports that it conducts on-site quality checks and final quality control and release in the Analytical Competence Center at the JRS Pharma facilities in Germany. The products will be warehoused in the JRS PHARMA central logistics center in Germany and the USA, thus enabling ease and speed of delivery.
Source: JRS Pharma
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
